Doxorubicin-loaded phosphatidylethanolamine-conjugated nanoliposomes: in vitro characterization and their accumulation in liver, kidneys, and lungs in rats

@article{Rudra2010DoxorubicinloadedPN,
  title={Doxorubicin-loaded phosphatidylethanolamine-conjugated nanoliposomes: in vitro characterization and their accumulation in liver, kidneys, and lungs in rats},
  author={A. Rudra and R. Deepa and M. K. Ghosh and Subhajit Ghosh and B. Mukherjee},
  journal={International Journal of Nanomedicine},
  year={2010},
  volume={5},
  pages={811 - 823}
}
Introduction Phosphatidylethanolamine (PE)-conjugated nanoliposomes were developed, characterized, and investigated for their accumulation in liver, kidneys, and lungs in rats. Methods Drug-excipient interaction was studied using Fourier transform infrared spectroscopy (FTIR), differential scanning calorimetry (DSC), surface morphology by field emission scanning electron microscopy, elemental analysis by energy dispersive X-ray (EDX) analysis, zeta potential and size distribution using a… Expand
Preparation and characterization of Tamoxifen citrate loaded nanoparticles for breast cancer therapy
TLDR
TNPs (NP4) showed the highest drug loading, released the drug in a sustained manner for a prolonged period of time and were taken up well by the MCF-7 breast cancer cell line in vitro, suggesting the formulation may be suitable for breast cancer treatment due to the good permeation of the formulation into the breast cancer cells. Expand
Garcinol-loaded novel cationic nanoliposomes: in vitro and in vivo study against B16F10 melanoma tumor model.
TLDR
Cationic nanoliposomal formulations could be a future medication for skin cancer treatment and revealed superiority of GAR-DPPC than Gar-DSPC and free GAR in melanoma prevention. Expand
Novel greenly synthesized titanium dioxide nanoparticles compared to liposomes in drug delivery: in vivo investigation on Ehrlich solid tumor model
TLDR
The greenly synthesized TiO2NPs were proved to be as effective as liposomes in enhancing the anticancer activity of Dox. Expand
Bicontinuous Cubic Liquid Crystalline Nanoparticles for Oral Delivery of Doxorubicin: Implications on Bioavailability, Therapeutic Efficacy, and Cardiotoxicity
TLDR
Incorporation of Dox in the novel LCNPs demonstrated improved antitumor efficacy and safety profile and can be a viable option for oral chemotherapy. Expand
Development of rosuvastatin flexible lipid-based nanoparticles: promising nanocarriers for improving intestinal cells cytotoxicity
TLDR
RSV loaded chitosomes nano-formulation could be considered as a promising nanocarrier system with a marked cytotoxic activity while, RSV loaded liposomal NPs are suitable nanoccarrier to improve RSV activity in treatment of cardiovascular disorders. Expand
Oral delivery of doxorubicin using novel polyelectrolyte-stabilized liposomes (layersomes).
TLDR
The positive results of the study strengthen the expectation that the developed formulation strategy can be fruitfully exploited to improve the oral deliverability of poorly bioavailable drugs and can open new vistas for oral chemotherapy. Expand
Nanoencapsulated Doxorubicin Prevents Mucositis Development in Mice
TLDR
Treatment with NLC–DOX attenuated DOX-induced mucositis in mice, improving shortening on villus height and crypt depth, decreased inflammatory parameters, preserved intestinal permeability and increased expression of tight junctions (ZO-1 and Ocludin). Expand
A novel biocompatible antibacterial product: Nanoliposomes loaded with poly(hexamethylene biguanide chloride)
In this study, nanoliposome-loaded poly(hexamethylene biguanide) is introduced as a novel biocompatible antibacterial product with higher activity than microliposomes. Soy lecithin as a clean productExpand
Magnetic Properties of Polyvinyl Alcohol and Doxorubicine Loaded Iron Oxide Nanoparticles for Anticancer Drug Delivery Applications
The current study emphasizes the synthesis of iron oxide nanoparticles (IONPs) and impact of hydrophilic polymer polyvinyl alcohol (PVA) coating concentration as well as anticancer drug doxorubicinExpand
PEGylated trimethylchitosan emulsomes conjugated to octreotide for targeted delivery of sorafenib to hepatocellular carcinoma cells of HepG2
TLDR
The results indicate that designed EMs may be promising for the treatment of hepatocellular carcinoma and showed that targeted EMs had more cytotoxicity than free sorafenib and non-targeted EMs. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 40 REFERENCES
The effect of PEG coating on in vitro cytotoxicity and in vivo disposition of topotecan loaded liposomes in rats.
TLDR
Results indicated that PEG modified liposome might be an effective carrier for topotecan, an amphoteric anticancer drug prepared by lipid film hydration method. Expand
Real time in vitro studies of doxorubicin release from PHEMA nanoparticles
TLDR
Suspension polymerization of 2-hydroxyethyl methacrylate (HEMA) results in the formation of swellable nanoparticles of defined composition, which can potentially be used for the controlled release of the anticancer drug doxorubicin. Expand
Preparation, characterization and in-vitro evaluation of sustained release protein-loaded nanoparticles based on biodegradable polymers
TLDR
The in-vitro protein release study suggests that release profile of BSA from nanoparticles could be modulated by changing protein-polymer ratios and/or by varying homogenizing speed during multiple-emulsion preparation technique. Expand
Sustained release of acyclovir from nano-liposomes and nano-niosomes: An in vitro study
TLDR
Niosome could be a better choice for intravenous delivery of acyclovir because of its good vesicular distributions and better stability compared with the liposomes. Expand
Targeted Delivery of Doxorubicin via Sterically Stabilized Immunoliposomes: Pharmacokinetics and Biodistribution in Tumor-bearing Mice
TLDR
The advantage of specific targeting of sterically stabilized liposomes is expressed mainly in increasing availability of DOX to tumor cells in a way which is dependent on tumor microanatomy. Expand
An improved method of encapsulation of doxorubicin in liposomes: pharmacological, toxicological and therapeutic evaluation.
TLDR
An improved method of encapsulating doxorubicin in liposomes using phosphatidylcholine, cholesterol and synthetic tetramyristoyl cardiolipin, providing enhanced therapeutic advantage and the ability to modulate multidrug resistance, could be useful in a clinical setting. Expand
Liposomal encapsulation of topotecan enhances anticancer efficacy in murine and human xenograft models.
TLDR
It is suggested that liposomal encapsulation can significantly enhance the therapeutic activity of topotecan and provide greatly improved increase in life span relative to the free drug in a human breast carcinoma model (MDA 435/LCC6). Expand
Preparation, characterization, and pharmacokinetic evaluation of puerarin submicron emulsion.
TLDR
The area under the whole blood concentration-time curve of rabbits after intravenous administration of puerarin emulsion was 1.718-fold higher than that of rabbits of intravenousadministration of perarin (P < 0.05), and the biological half-life and the mean retention time of puersin emulsion were markedly increased. Expand
Synthesis and evaluation of a novel ligand for folate-mediated targeting liposomes.
TLDR
The synthesis of a novel lipophilic folate derivative, folate-polyethylene glycol-cholesterol hemisuccinate, and its evaluation as a targeting ligand for liposomal doxorubicin (L-DOX) in FR-expressing cells suggest that F-PEG-CHEMS is effective as a novel ligand in the synthesis of FR-targeted liposomes. Expand
Comparative in vivo studies with paclitaxel and liposome-encapsulated paclitaxel.
TLDR
A significant decrease in toxicity shown by LET, coupled with an increase in plasma AUC and half-life indicates that LET may be a viable alternative to the therapeutic use of the conventional preparation of paclitaxel. Expand
...
1
2
3
4
...